cbdMD, Inc.
YCBD
$0.68
-$0.0249-3.53%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -10.96% | 8.52% | -4.87% | -20.21% | -15.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.96% | 8.52% | -4.87% | -20.21% | -15.45% |
| Cost of Revenue | 0.30% | -0.32% | -5.78% | -2.74% | -22.14% |
| Gross Profit | -16.82% | 14.67% | -4.41% | -30.86% | -11.49% |
| SG&A Expenses | -2.31% | -10.61% | -24.64% | -31.26% | -32.10% |
| Depreciation & Amortization | -2.64% | -1.62% | 5.04% | -56.92% | -23.38% |
| Other Operating Expenses | 11.08% | -71.19% | -40.41% | -127.81% | -48.18% |
| Total Operating Expenses | -0.80% | -11.68% | -19.27% | -43.30% | -30.05% |
| Operating Income | -136.83% | 68.68% | 91.90% | 89.02% | 79.05% |
| Income Before Tax | -294.76% | 84.03% | 101.52% | 99.04% | 125.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -294.76% | 84.03% | 101.52% | 99.04% | 125.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -294.76% | 84.03% | 101.52% | 99.04% | 125.97% |
| EBIT | -136.83% | 68.68% | 91.90% | 89.02% | 79.05% |
| EBITDA | -562.25% | 84.14% | 127.07% | 98.70% | 92.99% |
| EPS Basic | 82.35% | 82.44% | 67.90% | 98.95% | 87.08% |
| Normalized Basic EPS | 82.38% | 85.51% | 95.43% | 98.32% | 85.60% |
| EPS Diluted | 82.35% | 82.44% | 67.90% | 98.94% | 87.08% |
| Normalized Diluted EPS | 82.38% | 85.51% | 95.43% | 98.32% | 85.60% |
| Average Basic Shares Outstanding | 1,187.78% | 110.32% | 53.74% | 552.31% | 50.96% |
| Average Diluted Shares Outstanding | 1,187.78% | 110.32% | 53.74% | 552.31% | 50.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |